Déclaration d'accessibilité Sauter la navigation
  • Ressources
  • Journalistes
  • Relations investisseurs
  • Webdiffusion
  • English
  • mon CNW 
    • Ouvrir une session
    • Créez un compte
  • Ouvrir une session
  • Inscription
  • Envoyer
Cision Canada
  • Nouvelles
  • Produits
  • Nous joinder
Recherche
When typing in this field, a list of search results will appear and be automatically updated as you type.

Rechercher votre contenu...

Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

News Releases

view all
    Recherche avancée
    • Communiqués
        • Parcourir les communiqués

        • Tous les communiqués de presse
        • Tous les communiqués de sociétés publiques
        • Parcourir tous les communiqués

        • Galerie multimédia

        • Tous les communiqués avec multimédia
        • Tous les communiqués avec photos
        • Tous les communiqués avec vidéos
        • Voir toute la Galerie multimédia

        • Sujets d'actualité

        • Voir tous les sujets d'actualité
    • Affaires
        • Affaires Générales

        • Activités d'externalisation
        • Annonces relatives au personnel
        • Communiqués salon professionnel
        • Enquêtes, sondages et recherches
        • Expansion d'entreprise
        • Immobilier commercial
        • Immobilier résidentiel
        • Investissement socialement responsable
        • Licenciement
        • Nécrologie
        • Nouveaux produits et services
        • Récompenses
        • Ressources humaines et gestion des effectifs
        • Résultats financiers
        • Services aux petites entreprises
        • Transactions immobilières
        • Survol, Affaires Générales

        • Voir tout Affaires Générales

        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Secteur de l’automobile et du transport

        • Aérospatiale, défense
        • Automobile
        • Chaîne logistique / Logistique
        • Compagnies aériennes & Aviation
        • Fret aérien
        • Maritime & Construction navale
        • Tourisme et Voyages
        • Transport, camionnage et de chemin de fer
        • Transports routiers
        • Voies ferrées et transport intermodal
        • Survol, Secteur de l’automobile et du transport

        • Voir tout Secteur de l’automobile et du transport

        • Services financiers et investissements

        • Accords financiers
        • Acquisitions, fusions et rachats
        • Activisme actionnarial
        • Annonces de conférence de presse
        • Assurance
        • Capital de risque
        • Coentreprises
        • Contrats
        • Cryptomonnaie
        • Dividendes
        • Émission d'actions
        • Faillite
        • Fonds communs
        • Fractionnement d'actions
        • Immobilier
        • Nouvelles et dossiers
        • Obligations et actions
        • Opinions d'investissement
        • Placement privé
        • Prévisions de résultats & projections
        • Rapports des ventes
        • Restructuration & recapitalisation
        • Résultats financiers
        • Services bancaires & financiers
        • Survol, Services financiers et investissements

        • Voir tout Services financiers et investissements

        • Technologies des affaires

        • Analyse de données
        • Automatisation de la conception électronique
        • Chaîne de blocs
        • Commerce électronique
        • Composants électroniques
        • Informatique et électronique
        • Logiciel informatique
        • Matériel informatique
        • Nanotechnologie
        • Périphériques
        • Réseaux
        • Sécurité haute technologie
        • Semi-conducteurs
        • Technologie de radiodiffusion
        • Technologie financière
        • Technologie Internet
        • Survol, Technologies des affaires

        • Voir tout Technologies des affaires

    • Sciences et technologie
        • Énergie et ressources naturelles

        • Chimie
        • Commodités
        • Découvertes en matière de pétrole et de gaz
        • Énergies alternatives
        • Fabrication générale
        • Gaz
        • Mines
        • Mines & Métaux
        • Pétrole & Énergie
        • Services d'eau
        • Services d'électricité
        • Survol, Énergie et ressources naturelles

        • Voir tout Énergie et ressources naturelles

        • Environnement

        • Catastrophes naturelles
        • Conservation & Recyclage
        • Politique environnementale
        • Problèmes environnementaux
        • Produits et services environnementaux
        • Technologie verte
        • Survol, Environnement

        • Voir tout Environnement

        • Industries lourdes et manufacturières

        • Aéronautique & Défense
        • Agriculture
        • Chimie
        • Construction & Bâtiment
        • CVC (Chauffage, ventilation et climatisation)
        • Fabrication générale
        • Machinerie
        • Machines-outils, travail des métaux et métallurgie
        • Métaux précieux
        • Mine
        • Mines & Métaux
        • Papier, produits forestiers et conteneurs
        • Tabac
        • Textiles
        • Survol, Industries lourdes et manufacturières

        • Voir tout Industries lourdes et manufacturières

        • Technologie de consommation

        • Analyse de données
        • Chaîne de blocs
        • Chaîne logistique / Logistique
        • Commerce électronique
        • Communications sans fil
        • Cryptomonnaie
        • Divertissement mobile
        • Électronique de consommation
        • Infonuagique / Internet des objets
        • Informatique et électronique
        • Intelligence artificielle
        • Jeux électroniques
        • Logiciel informatique
        • Matériel informatique
        • Médias sociaux
        • Multimédia & Internet
        • Périphériques
        • STIM (Science, technologie, ingénierie, mathématiques)
        • Technologie financière
        • Survol, Technologie de consommation

        • Voir tout Technologie de consommation

        • Télécommunications

        • Carrières et services
        • Communications sans fil
        • Divertissement mobile
        • Équipement de télécommunication
        • Industrie de la télécommunication
        • Périphériques
        • Réseaux
        • VoIP (voix sur IP)
        • Survol, Télécommunications

        • Voir tout Télécommunications

    • Santé et style de vie
        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Produits de consommation et vente au détail

        • Aliments biologiques
        • Aliments et boissons
        • Animaux et animaux domestiques
        • Bières, vins et spiritueux
        • Bijoux
        • Boissons
        • Boissons non-alcoolisées
        • Cannabis
        • Commerce
        • Jouets
        • Ménages, Consommateurs, Cosmétiques
        • Meubles et ameublement
        • Mode
        • Produits cosmétiques et soins personnels
        • Produits d'entretien domestique
        • Produits de bureau
        • Rappels de produit
        • Rénovation domiciliaire
        • Restaurants
        • Services nuptiaux
        • Supermarchés
        • Survol, Produits de consommation et vente au détail

        • Voir tout Produits de consommation et vente au détail

        • Santé

        • Approbation médicale internationale
        • Assurance santé
        • Biométrique
        • Biotechnologie
        • Conditionnement physique / Mieux-être
        • Contrôle des infections
        • Dentisterie
        • Équipement médical
        • Essais cliniques & de Découvertes Médicales
        • Homologation de la FDA
        • Médecines complémentaires
        • Pharmaceuticals médicaux
        • Pharmaceutiques
        • Santé mentale
        • Soins de santé & hôpitaux
        • Survol, Santé

        • Voir tout Santé

        • Sports

        • Équipements et accessoires de sport
        • Événements sportifs
        • Plein air, camping, randonnée pédestre
        • Sports en général
        • Survol, Sports

        • Voir tout Sports

        • Tourisme et Voyages

        • Hôtels et stations
        • Hôtels et stations
        • Industrie du voyage
        • Loisirs et tourisme
        • Parcs d'attraction et attractions touristiques
        • Plein air, camping, randonnée pédestre
        • Trafic aérien de passagers
        • Survol, Tourisme et Voyages

        • Voir tout Tourisme et Voyages

    • Politique et intérêt public
        • Politique et intérêt public

        • Actualités, tendances, analyses économiques
        • Actualités syndicales
        • Bien-être de l'animal
        • But non lucratif
        • Catastrophes naturelles
        • Direction & Agence fédérale exécutif
        • Éducation
        • Environnement
        • Gouvernement européen
        • Homologation de la FDA
        • Législation fédérale et nationale
        • Opinion du groupe de défense des droits
        • Politique commerciale
        • Politique étrangère
        • Politique fédérale
        • Politique intérieure
        • Politique municipale
        • Politique provinciale
        • Questions juridiques
        • Responsabilité sociale de l'entreprise
        • Sécurité intérieure
        • Sécurité publique
        • Survol, Politique et intérêt public

        • Voir tout Politique et intérêt public

    • Société
        • Société

        • Actualités liées aux Afro-américains
        • Actualités liées aux Asiatiques
        • Actualités liées aux enfants
        • Actualités liées aux femmes
        • Actualités liées aux personnes handicapées
        • Actualités orientées vers les hispaniques
        • Anciens combattants
        • Autochtones, Premières Nations et Amérindiens
        • Diversité, équité & inclusion
        • Intérêt des hommes
        • Lesbienne, Homosexuel, Bisexuel
        • Personnes du troisième âge
        • Religion
        • Survol, Société

        • Voir tout Société

    • Recherche avancée
    • Découvrir la plateforme
    • Planifier des campagnes
    • Créer avec l'IA
    • Diffuser des communiqués
    • Mesurer vos résultats
    • Amplifier le contenu
    • Devenir un client
    • Demandez une démo
    • Bureaux d'édition
    • Partenariats
    • Renseignements généraux
    • Médias
    • Bureaux Mondiaux
    • Hamburger menu
    • Cision Canada
    • Envoyer
    • EN
      • Téléphone

      • 877-269-7890 de 8h00 à 22h00

      • Contactez Cision
      • Contactez Cision

        877-269-7890
        de 8h00 à 22h00

    • Rechercher votre contenu...

      Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

      News Releases

      view all
      Close menu
    • Nouvelles
    • Produits
    • Nous joinder
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • 3 Communiqués
      • 5 Affaires
      • 5 Sciences et technologie
      • 5 Santé et style de vie
      • 1 Politique et intérêt public
      • 1 Société
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Découvrir la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifier le contenu
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Devenir un client
      • Demandez une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux Mondiaux
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      Close submenu (Communiqués) Communiqués
      • Parcourir les communiqués
      • Galerie multimédia
      • Sujets d'actualité
      Close submenu (Affaires) Affaires
      • Affaires Générales
      • Divertissement et médias
      • Secteur de l’automobile et du transport
      • Services financiers et investissements
      • Technologies des affaires
      Close submenu (Sciences et technologie) Sciences et technologie
      • Énergie et ressources naturelles
      • Environnement
      • Industries lourdes et manufacturières
      • Technologie de consommation
      • Télécommunications
      Close submenu (Santé et style de vie) Santé et style de vie
      • Divertissement et médias
      • Produits de consommation et vente au détail
      • Santé
      • Sports
      • Tourisme et Voyages
      Close submenu (Politique et intérêt public) Politique et intérêt public
      • Politique et intérêt public
      Close submenu (Société) Société
      • Société

      Dialogue Health Technologies Reports Third Quarter 2022 Results

      Dialogue Logo (CNW Group/Dialogue Health Technologies Inc.)

      Nouvelles fournies par

      Dialogue Health Technologies Inc.

      14 nov, 2022, 17:00 ET

      Partager cet article

      Partager cet article


      Strong performance fueled by $6 million in new ARR, 52% growth in the digital business, and significant progress towards profitability objectives

      MONTREAL, Nov. 14, 2022 /CNW/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"), Canada's premier health and wellness virtual healthcare platform, announced today its financial and operational results for the three and nine months ended September 30, 2022. Financial references are in Canadian dollars unless otherwise indicated.

      "Dialogue delivered solid performance across all services. We generated 37% growth in revenue year-over-year, improved our gross margin significantly, and demonstrated strong cost discipline. Importantly, our core business, the Dialogue Integrated Health PlatformTM, was particularly robust with growth of 52% year-over-year," said Cherif Habib, Chief Executive Officer of Dialogue. "Despite the challenging macroeconomic environment, the employment backdrop remains healthy in Canada, and organizations continue to invest in their employee benefits and support. At the same time, we are maintaining our focus on improving the member experience, delivering better health and wellness outcomes, and making high-quality care more convenient and more accessible to all."

      Navaid Mansuri, Chief Financial Officer, added: "We delivered a solid quarter for shareholders and continued to invest responsibly towards the execution of our long-term strategy. We focused on driving growth, adding $6 million of new Annual Recurring Revenue, and made steady improvements in our platform and business. We stayed the course with our profitability objectives, reducing the adjusted EBITDA loss to $3.9 million, and, through strong working capital management, used less than $2.5 million of cash. We remain excited by the opportunities we see ahead and confident in our ability to maintain our leadership position in the market."

      Q3 2022 Financial Highlights
      (All capitalized terms not defined herein, shall have the meaning and usefulness ascribed to them in the Management's Discussion and Analysis for the three and nine months ended September 30, 2022. Comparison periods in each case are the three and nine months ended September 30, 2021, unless otherwise stated.)

      • Annual Recurring and Reoccurring Revenue ("ARR") grew 29.7% year-over-year to $97.8 million, driven by new Customer wins and by our acquisition of Tictrac Ltd. ("Tictrac"), but offset in large part by a decline in foreign currencies and by the non-renewal of a customer in our legacy Optima business. Dialogue's core digital business in Canada, which represents nearly 80% of the overall ARR, increased 51% year-over-year. New customer wins in the third quarter of 2022 include a global packaging equipment manufacturer and a national fashion retail chain. Moreover, our relationship with a leading provider of student health plans in Canada continues to expand, as many colleges and universities take important steps to support the health and well-being of their students. We also saw the addition of new services by several existing Customers, including a leading distributor of automotive parts.
      • Revenue in the third quarter of 2022 increased by 37.0% year-over-year to $23.6 million, due to growth in Members, both Direct and from agreements with strategic distribution partners, an increase in the Attach Rate as existing Customers add more services, and the acquisition of Tictrac.
      • Members grew to more than 2.7 million, an increase of approximately 950,000, or 53.9%, year-over-year, and nearly 320,000, or 13.2%, compared to the second quarter of 2022. Excluding the contribution from Tictrac, Members grew 38.5% year-over-year to more than 2.4 million.
      • Attach Rate grew to 1.53 from 1.11in the third quarter last year.
      • Member-Service Units ("MSUs"), which we define as total Members multiplied by the Attach Rate, rose 112.1% year-over-year to nearly 4.2 million from approximately 2.0 million in the third quarter last year. Excluding the contribution from Tictrac, MSUs grew 98.5% year-over-year to nearly 3.9 million. This increase demonstrates the success of Dialogue's land & expand strategy, as both existing and new Customers continue to leverage our integrated services.
      • 65% of new direct Members signed up for two services or more in the third quarter of 2022. Combined with current Customer expansions, the cumulative number of direct Members with two or more services was 30% at the end of the third quarter of 2022, compared to 17% at the same time last year and 21% at the end of the fourth quarter of 2021.
      • Average Monthly Net Retention Rate ("NRR") was 101.5% for the third quarter of 2022, marking another consecutive quarter of NRR greater than 100%. Churn within our mid-market and enterprise customer segments remained low in the period at approximately 2,800 members.
      • Gross Margin increased to 52.2%, compared to 42.6% in the third quarter of 2021, as we realized efficiencies in our operations, continued to implement pricing increases to eligible Customers, continued to scale our Mental Health service and Employee Assistance Program ("EAP"), and integrated Tictrac's higher margin Wellness service.
      • Adjusted EBITDA1 loss was $3.9 million, compared to a loss of $4.9 million in the same period last year. The smaller loss was due to higher gross profit and strong cost control, partially offset by a deficit at Tictrac.
      • Net loss was $6.0 million, compared to $6.3 million in the same period last year. The smaller loss in the third quarter of 2022 was primarily due to a larger deferred income tax recovery compared to the third quarter of 2021.
      • Cash and Cash Equivalents were $58.7 million as of September 30, 2022, compared to $104.3 million as of December 31, 2021. The decrease was the result of cash used in operations during the first nine months of the year as well as the initial cash outlay to close the acquisition of Tictrac.

      Q3 2022 Business Highlights and Subsequent Events

      • On July 4, 2022, Sun Life added Dialogue's Mental Health service to their Lumino Health Virtual Care platform. On September 1, 2022, Canada Life added Dialogue's Mental Health service and EAP to the Consult+ app. In both cases, these additional service are available to plan sponsors on an opt-in basis and now permit our largest insurance partners to offer more services from Dialogue's Integrated Health PlatformTM.
      • On September 2, we surpassed the 1 million member milestone in our Direct customer channel.
      • Subsequent to quarter end, on October 2, 2022, Sterling Capital Brokers, Canada's largest independent benefits consultant, partnered with Dialogue to promote health living by offering our Wellness program to its current and prospective customers.
      • Subsequent to quarter end, on October 11, 2022, myHSA Ltd., an employee benefits platform, announced a partnership with Dialogue that allows advisors to offer Dialogue's full suite of services, including Wellness, to organizations in Canada, through an easy-to-use central application.
      • On November 1, 2022, Dialogue became the first virtual care company to receive the Accreditation Canada Primer award, recognizing a high level of quality and safety of care.
      • We were recognized by Great Place to Work® in the 2022 Best WorkplacesTM in Healthcare.
      • We were ranked #29 on the 2022 Report on Business list of Canada's Top Growing Companies with a three-year revenue growth of 1,596%.

      Financial Outlook

      Dialogue is providing an outlook based on current market conditions and expectations. For the fourth quarter of 2022, we expect:

      • Revenue to be in the range of $24.5 million to $25.0 million.
      • Gross profit margin to be in the range of 51.0% to 53.0%.
      • Adjusted EBITDA to be in the range of ($3.0) million to ($2.5) million.

      Upcoming Events

      • National Bank Financial Technology Conference in Toronto on December 7, 2022.

      Notice of Conference Call

      Dialogue will host a live video webinar on Tuesday, November 15, 2022 at 8:30 a.m. ET to discuss its financial results. Cherif Habib, CEO, and Navaid Mansuri, CFO, will co-chair the call. All interested parties can join the event at the following link, which is also available in the Events and Presentations section of the Company's website. The presentation will be accompanied by slides, which will be available on the screen view and will be made available prior to the start of the webinar on  the Company's website. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download of Zoom that may be required to attend the event. Listeners that prefer to dial in by phone may do so by accessing the same web link and the dial in details will be provided by email upon registration.

      Non-International Financial Reporting Standards ("IFRS") Financial Measures

      This press release makes reference to certain non-IFRS measures, such as "EBIT" (which stands for net profit or loss before net financing (income) expenses and income taxes), "EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets and amortization of right-of-use assets) and "Adjusted EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, amortization of right-of-use assets, transaction costs, acquisition costs, change in fair value of conversion feature, share-based payments expense, change in fair value of contingent consideration, restructuring costs and foreign exchange gain or loss). These measures are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information as reported under IFRS. We also believe that other users, such as securities analysts, investors and other interested parties, frequently use non-IFRS measures, particularly in the evaluation of issuers.

      Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Where applicable, we provide a clear quantitative reconciliation from the non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS.

      The following table reconciles net loss to Adjusted EBITDA loss for the three and nine months ended September 30, 2022 and 2021:

      DIALOGUE HEALTH TECHNOLOGIES INC.
      ADJUSTED EBITDA
      FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 and 2021

      (in thousands of CAD)


      Three months ended

      September 30,


      Nine months ended

      September 30,



      2022


      2021


      2022


      2021



      $


      $


      $


      $










      Net loss


      (5,992)


      (6,305)


      (21,446)


      (244,211)

      Net financing income


      (276)


      (217)


      (470)


      (155)

      Current income tax expense


      36


      —


      84


      —

      Deferred income tax recovery


      (538)


      (90)


      (789)


      (244)

      EBIT


      (6,770)


      (6,612)


      (22,621)


      (244,610)

      Depreciation of property and equipment


      52


      81


      456


      347

      Amortization of intangible assets


      669


      421


      1,575


      1,125

      Amortization of right-of-use assets


      223


      150


      574


      448

      EBITDA


      (5,826)


      (5,960)


      (20,016)


      (242,690)

      Share-based payments expense


      1,090


      997


      2,612


      1,384

      Acquisition costs


      356


      49


      990


      230

      Change in fair value of conversion feature


      —


      —


      —


      225,417

      Change in fair value of contingent consideration


      133


      —


      267


      —

      Restructuring costs


      39


      —


      53


      —

      Foreign exchange loss (gain)


      275


      —


      1,609


      87

      Adjusted EBITDA


      (3,933)


      (4,914)


      (14,485)


      (15,572)


      About Dialogue

      Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

      Forward-Looking Information

      This release includes "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking information may relate to our financial outlook (including revenues and Adjusted EBITDA), and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives.

      In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as "plans" "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

      Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Dialogue as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under "Risk Factors" in the Company's latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities in Canada, all of which are available under the Company's SEDAR profile at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Dialogue. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Dialogue undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws.

      Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not currently known to us or that we currently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information. The forward-looking information represents our expectations as of the date of this earnings release (or as the date it is otherwise stated to be made) and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. All of the forward-looking information contained in this earnings release is expressly qualified by the foregoing cautionary statements.

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF NET LOSS AND OTHER COMPREHENSIVE INCOME (LOSS)
      FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

      (in thousands of CAD except share and per share data)

      Three months ended

      September 30,


      Nine months ended

      September 30,


      2022


      2021


      2022


      2021


      $


      $


      $


      $









      Revenue

      23,614


      17,235


      67,338


      49,133

      Cost of services

      11,295


      9,891


      34,814


      28,550

      Gross profit

      12,319


      7,344


      32,524


      20,583









      Operating expenses








      General and administrative

      12,084


      7,955


      35,201


      23,788

      Sales and marketing

      3,116


      2,940


      9,505


      8,337

      Product and development

      2,799


      2,064


      7,827


      6,267

      Share-based payments expense

      1,090


      997


      2,612


      1,384


      19,089


      13,956


      55,145


      39,776









      Operating loss

      (6,770)


      (6,612)


      (22,621)


      (19,193)









      Other expenses








      Change in fair value of conversion feature

      —


      —


      —


      225,417

      Net financing income

      (276)


      (217)


      (470)


      (155)


      (276)


      (217)


      (470)


      225,262









      Net loss before income taxes

      (6,494)


      (6,395)


      (22,151)


      (244,455)

      Current income tax expense

      36


      —


      84


      —

      Deferred income tax recovery

      (538)


      (90)


      (789)


      (244)

      Net loss

      (5,992)


      (6,305)


      (21,446)


      (244,211)

















      Other comprehensive (loss) income















      Items that may be reclassified subsequently to net loss







      Foreign currency translation (loss) gain

      (352)

      (94)


      261


      535









      Total comprehensive loss

      (6,344)


      (6,399)


      (21,185)


      (243,676)









      Loss per share - basic and diluted

      (0.09)


      (0.10)


      (0.32)


      (4.62)


      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
      AS AT SEPTEMBER 30, 2022 AND DECEMBER 31, 2021

      (in thousands of CAD)

      September 30,


      December 31,




      2022


      2021




      $


      $



      Assets






      Current assets






      Cash and cash equivalents

      58,738


      104,296



      Trade and other receivables

      19,932


      13,659



      Prepaid expenses

      3,121


      1,811




      81,791


      119,766









      Investment

      1,004


      —



      Property and equipment

      1,181


      1,137



      Right-of-use assets

      1,571


      1,568



      Intangible assets

      8,548


      5,819



      Goodwill

      27,426


      6,963



      Deferred income tax asset

      3,464


      —




      124,985


      135,253



      Liabilities






      Current liabilities






      Trade payable and accrued liabilities

      14,783


      9,534



      Unearned revenue

      489


      68



      Current portion of contingent consideration payable

      3,977


      718



      Current portion of long-term debt

      400


      400



      Current portion of lease liabilities

      798


      541




      20,447


      11,261









      Non-current portion of lease liabilities

      573


      911



      Non-current portion of long-term debt

      807


      1,074



      Non-current portion of contingent consideration payable

      716


      1,300



      Deferred income tax liability

      764


      766




      23,307


      15,312



      Commitments and contingencies












      Shareholders' equity






      Share capital

      459,446


      458,962



      Equity reserve

      5,952


      3,514



      Cumulative translation adjustment

      608


      347



      Deficit

      (364,328)


      (342,882)




      101,678


      119,941




      124,985


      135,253










      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
      FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

      (in thousands of CAD)

      Nine months ended

      September 30,


      2022


      2021


      $


      $

      Operating activities




      Net loss

      (21,446)


      (244,211)

      Items not affecting cash




      Increase on contingent consideration

      267


      (358)

      Foreign Exchange gain on contingent consideration

      (38)


      —

      Deferred income tax recovery

      (789)


      (244)

      Change in conversion feature on preferred shares

      —


      225,417

      Depreciation of property and equipment

      456


      347

      Amortization of right-of-use assets

      574


      448

      Net financing income

      (470)


      (155)

      Amortization of intangible assets

      1,575


      1,125

      Loss on intangible assets write-off

      115


      —

      Share-based payments

      2,612


      1,384


      (17,144)


      (16,247)

      Net changes in non-cash operating working capital items




      Trade and other receivables

      (6,273)


      (470)

      Prepaid expenses

      (1,310)


      (1,657)

      Trade and other payables

      5,249


      1,328

      Unearned revenue

      421


      (266)

      Interest paid

      (138)


      (113)

      Interest income

      519


      544


      (18,676)


      (16,881)

      Investing activities




      Purchase of property and equipment

      (442)


      (473)

      Purchase of intangible assets

      —


      (87)

      Sale of asset held for sale

      —


      910

      Acquisition of Botfront

      —


      (292)

      Acquisition of e-hub Health Pty Ltd. net of cash acquired

      —


      (3,138)

      Investment

      (1,004)


      —

      Payment of Optima contingent consideration

      —


      (1,500)

      Payment of Botfront contingent consideration

      —


      (199)

      Payment of e-Hub Health Pty Ltd. contingent consideration

      (849)


      —

      Acquisition of Tictrac Ltd. net of cash acquired

      (24,253)


      —


      (26,548)


      (4,779)

      Financing activities




      Issuance of shares

      —


      100,008

      Share issue costs

      —


      (9,371)

      Performance share units settled in cash

      (172)


      —

      Options exercised

      484


      537

      Repayment of liability related to asset held for sale

      —


      (430)

      Repayment of long-term debt

      (200)


      (300)

      Repayment of lease liabilities

      (707)


      (507)


      (595)


      89,937

      Effect of foreign currency translation

      261


      535

      Net (decrease) increase in cash and cash equivalents

      (45,558)


      68,812

      Cash and cash equivalents, beginning of the period

      104,296


      42,067

      Cash and cash equivalents, end of the period

      58,738


      110,879

      SOURCE Dialogue Health Technologies Inc.

      Investor relations, Jean Marc Ayas, Director, Investor Relations, [email protected]; Media Relations, Jean-Christophe de Le Rue, Director, Public and Government Relations, [email protected] / (613) 806-0671

      Modal title

      Profil de l'entreprise

      Dialogue Health Technologies Inc.

        Autres communiqués de la compagnie

      • Dialogue lance le Profil de Santé pour aider les Canadiens à comprendre leurs risques de santé et à agir

      • Le bien-être des employés canadiens continue de décliner alors que les employeurs peinent à mesurer et à améliorer les résultats

      • Une étude révèle que les soins virtuels de santé mentale financés par l'employeur pourraient faire économiser 22 milliards de dollars par année au Canada

      Communiquer avec PR Newswire

      • 877-269-7890
        De 7 h 30 à 18 h 30 (HE)
      • Devenir un client
      • Demander une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux mondiaux

      Produits

      • Découvrez la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifiez le contenu
      • Relations investisseurs

      À propos

      • À propos de Cision
      • Carrières
      • Énoncé d'accessibilité

      Services

      • Toutes les nouvelles
      • Connexion à la plateforme
      • mon CNW
      • Protection des données

      Ne pas vendre ou partager mes informations personnelles:

      • Soumettre à [email protected] 
      • Appelez gratuitement notre département de la protection de la vie privée: 877-297-8921

      Communiquer avec Cision

      Produits

      À propos

      Services
      • Toutes les nouvelles
      • Comms Cloud Nouvelle Génération
      • Cision Communications Cloud®
      • Plateforme
      • mon CNW
      877-269-7890
      de 8h00 à 22h00
      • Modalités d'utilisation
      • Politique sur la sécurité des données
      • Plan du site
      • Paramètres de cookies
      • Énoncé d'accessibilité
      © Groupe CNW Ltée 2026 Tous droits réservés. Une société Cision.